HEALTHCARE
Global Implantable Insulin Pumps Market - Industry Trends and Forecast to 2032
REPORT OVERVIEW
Global Implantable Insulin Pumps Market, By Device Type (Closed-loop Insulin Pump and Open-loop Insulin Pump), Disease Indication (Type I Diabetes and Type II Diabetes), End Use (Hospitals, Clinics, Homecare Settings, and Others), Region (North America, Europe, Asia-Pacific, South America, Middle East and Africa) – Industry Trends and Forecast to 2032.
Market Insights
The global Implantable Insulin Pumps market size is valued to be USD xx million in 2023 and is expected to reach USD xx million by 2032, and it is expected to register a CAGR of xx% over the forecast period 2024-2032.
Insulin is a hormone produced by the pancreas that plays a crucial role in regulating blood sugar (glucose) levels in the body. It is essential for the proper functioning of various physiological processes, particularly in controlling how cells utilize glucose for energy. Implantable insulin pumps are medical devices designed to deliver insulin directly into the body to manage diabetes. Unlike traditional insulin pumps that are worn externally, implantable pumps are surgically implanted under the skin and provide a more convenient and precise insulin delivery, often reducing the need for frequent injections and improving glucose control.
The global implantable insulin pumps market refers to the segment of the medical device industry focused on devices designed to deliver insulin continuously to individuals with diabetes.
The respective global report analyses market trends, consumer behaviour and industry dynamics to guide towards entry into new markets with ease. Also, it assists in tailoring market specific and related products and services to meet the needs, preferences, and expectations of target audience by delving into their psychology. The report also specializes with comprehensive and extensive competitive analysis which offers useful insights into competitor strengths, weaknesses, opportunities, and threats. The respective report offers exclusive insights into the potential impact of disruptive developments and technologies that are expected to completely transform corporate operations. The context includes tailor-made research solutions to create a stronger footprint in their particular industries thereby offering dedicated customized solutions according to the client needs which helps in addressing unique business challenges with more simplified and efficient decision-making solutions.
Market Dynamics
DRIVERS
- Advantages over traditional insulin delivery
- Patient preference and compliance
RESTRAINTS
- Requirement of surgical implantation
- High costs
OPPORTUNITIES
- Global aging population
- Remote monitoring and telehealth
CHALLENGES
- Risk of device malfunction
- Patient acceptance and education
SEGMENTATION
- Device Type
- Closed-loop Insulin Pump
- Open-loop Insulin Pump
- Disease Indication
- Type I Diabetes
- Type II Diabetes
- End Use
- Hospitals
- Clinics
- Homecare Settings
- Others
The respective global report is completely customizable specific to regions (North America, Europe, Asia-Pacific, South America, Middle East and Africa), countries, and segments as per the client requirements.
REGIONAL SEGMENTATION
- North America
- U.S.
- Canada
- Mexico
- Rest of North America
- Europe
- Germany
- U.K.
- France
- Italy
- Spain
- Russia
- The Netherlands
- Belgium
- Turkey
- Rest of Europe
- Asia-Pacific
- China
- India
- Japan
- South Korea
- Singapore
- Malaysia
- Australia
- Thailand
- Philippines
- Rest of Asia-Pacific
- South America
- Brazil
- Argentina
- Chile
- Colombia
- Rest of South America
- Middle East and Africa
- Kingdom of Saudi Arabia
- South Africa
- U.A.E.
- Egypt
- Rest of Middle East and Africa
KEY MARKET PLAYERS
- Medtronic plc
- F. Hoffmann-La Roche AG
- SOOIL Developments Co. Ltd.
- Diamesco Co., Ltd.
- Apex Medical Devices
- Tandem Diabetes Care
- Johnson and Johnson Services Inc.
- Insulet Corporation
- Aetna Inc.
- Diabeloop SACA
Table OF CONTENTS
- SECTION 1 - INTRODUCTION
- 1.1 Taxonomy
- 1.2 Market Overview
- 1.3 Currency and Limitations
- 1.3.1 Currency
- 1.3.2 Limitations
- 1.4 Key Competitors
- SECTION 2 - RESEARCH METHODOLOGY
- 2.1 Research Approach
- 2.2 Data Collection and Validation
- 2.2.1 Secondary Research
- 2.2.2 Primary Research
- 2.3 Market Assessment
- 2.3.1 Market Size Estimation
- 2.3.2 Bottom-up Approach
- 2.3.3 Top-down Approach
- 2.3.4 Growth Forecast
- 2.4 Market Study Assumptions
- 2.5 Data Sources
- SECTION 3 - EXECUTIVE SUMMARY
- 3.1 Global Implantable Insulin Pumps Market, by Device Type
- 3.2 Global Implantable Insulin Pumps Market, by Disease Indication
- 3.3 Global Implantable Insulin Pumps Market, by End Use
- 3.4 Global Implantable Insulin Pumps Market, by Geography
- 3.5 Market Position Grid
- SECTION 4 - PREMIUM INSIGHTS
- 4.1 Regulatory Framework
- 4.1.1 Standards
- 4.1.2 Regulatory Landscape
- 4.2 Value Chain Analysis
- 4.3 Supply Chain Analysis
- 4.4 COVID-19 Impact
- 4.5 Russia-Ukraine War Impact
- 4.6 PORTER's Five Force Analysis
- 4.7 PESTLE Analysis
- 4.8 SWOT Analysis
- 4.9 Go to Market Strategy
- 4.10 Opportunity Orbit
- 4.11 Multivariate Modelling
- 4.12 Pricing Analysis
- SECTION 5 - MARKET DYNAMICS
- 5.1 Trends
- 5.1.1 Increasing prevalence of diabetes
- 5.1.2 Shift towards personalized medicine
- 5.1.3 Trend 3
- 5.2 Drivers
- 5.2.1 Advantages over traditional insulin delivery
- 5.2.2 Patient preference and compliance
- 5.2.3 Driver 3
- 5.2.4 Driver 4
- 5.3 Restraints
- 5.3.1 Requirement of surgical implantation
- 5.3.2 High costs
- 5.3.3 Restraint 3
- 5.4 Opportunities
- 5.4.1 Global aging population
- 5.4.2 Remote monitoring and telehealth
- 5.4.3 Opportunity 3
- 5.4.4 Opportunity 4
- 5.5 Challenges
- 5.5.1 Risk of device malfunction
- 5.5.2 Patient acceptance and education
- 5.5.3 Challenge 3
- SECTION 6 - GLOBAL IMPLANTABLE INSULIN PUMPS MARKET, BY DEVICE TYPE
- 6.1 Device Type Summary
- 6.2 Market Attractive Index
- 6.3 Global Implantable Insulin Pumps Market, by Device Type (2019-2032)
- SECTION 7 - GLOBAL IMPLANTABLE INSULIN PUMPS MARKET, BY DISEASE INDICATION
- 7.1 Disease Indication Summary
- 7.2 Market Attractive Index
- 7.3 Global Implantable Insulin Pumps Market, by Disease Indication (2019-2032)
- SECTION 8 - GLOBAL IMPLANTABLE INSULIN PUMPS MARKET, BY END USE
- 8.1 End Use Summary
- 8.2 Market Attractive Index
- 8.3 Global Implantable Insulin Pumps Market, by End Use (2019-2032)
- SECTION 9 - GLOBAL IMPLANTABLE INSULIN PUMPS MARKET, BY GEOGRAPHY
- 9.1 Regional Summary
- 9.2 Market Attractive Index
- 9.3 Global Implantable Insulin Pumps Market, by Geography (2019-2032)
- SECTION 10 - NORTH AMERICA IMPLANTABLE INSULIN PUMPS MARKET
- 10.1 North America Summary
- 10.2 Market Attractive Index
- 10.3 North America Implantable Insulin Pumps Market, by Device Type (2019-2032)
- 10.4 North America Implantable Insulin Pumps Market, by Disease Indication (2019-2032)
- 10.5 North America Implantable Insulin Pumps Market, by End Use (2019-2032)
- 10.6 North America Implantable Insulin Pumps Market, by Country (2019-2032)
- 10.6.1 U.S.
- 10.6.2 Canada
- 10.6.3 Mexico
- 10.6.4 Rest of North America
- SECTION 11 - EUROPE IMPLANTABLE INSULIN PUMPS MARKET
- 11.1 Europe Summary
- 11.2 Market Attractive Index
- 11.3 Europe Implantable Insulin Pumps Market, by Device Type (2019-2032)
- 11.4 Europe Implantable Insulin Pumps Market, by Disease Indication (2019-2032)
- 11.5 Europe Implantable Insulin Pumps Market, by End Use (2019-2032)
- 11.6 Europe Implantable Insulin Pumps Market, by Country (2019-2032)
- 11.6.1 Germany
- 11.6.2 U.K.
- 11.6.3 France
- 11.6.4 Italy
- 11.6.5 Spain
- 11.6.6 Russia
- 11.6.7 The Netherlands
- 11.6.8 Belgium
- 11.6.9 Turkey
- 11.6.10 Rest of Europe
- SECTION 12 - ASIA-PACIFIC IMPLANTABLE INSULIN PUMPS MARKET
- 12.1 Asia-Pacific Summary
- 12.2 Market Attractive Index
- 12.3 Asia-Pacific Implantable Insulin Pumps Market, by Device Type (2019-2032)
- 12.4 Asia-Pacific Implantable Insulin Pumps Market, by Disease Indication (2019-2032)
- 12.5 Asia-Pacific Implantable Insulin Pumps Market, by End Use (2019-2032)
- 12.6 Asia-Pacific Implantable Insulin Pumps Market, by Country (2019-2032)
- 12.6.1 China
- 12.6.2 India
- 12.6.3 Japan
- 12.6.4 South Korea
- 12.6.5 Singapore
- 12.6.6 Malaysia
- 12.6.7 Australia
- 12.6.8 Thailand
- 12.6.9 Philippines
- 12.6.10 Rest of Asia-Pacific
- SECTION 13 - SOUTH AMERICA IMPLANTABLE INSULIN PUMPS MARKET
- 13.1 South America Summary
- 13.2 Market Attractive Index
- 13.3 South America Implantable Insulin Pumps Market, by Device Type (2019-2032)
- 13.4 South America Implantable Insulin Pumps Market, by Disease Indication (2019-2032)
- 13.5 South America Implantable Insulin Pumps Market, by End Use (2019-2032)
- 13.6 South America Implantable Insulin Pumps Market, by Country (2019-2032)
- 13.6.1 Brazil
- 13.6.2 Argentina
- 13.6.3 Chile
- 13.6.4 Colombia
- 13.6.5 Rest of South America
- SECTION 14 - MIDDLE EAST AND AFRICA IMPLANTABLE INSULIN PUMPS MARKET
- 14.1 Middle East and Africa Summary
- 14.2 Market Attractive Index
- 14.3 Middle East and Africa Implantable Insulin Pumps Market, by Device Type (2019-2032)
- 14.4 Middle East and Africa Implantable Insulin Pumps Market, by Disease Indication (2019-2032)
- 14.5 Middle East and Africa Implantable Insulin Pumps Market, by End Use (2019-2032)
- 14.6 Middle East and Africa Implantable Insulin Pumps Market, by Country (2019-2032)
- 14.6.1 Kingdom of Saudi Arabia
- 14.6.2 South Africa
- 14.6.3 U.A.E.
- 14.6.4 Egypt
- 14.6.5 Rest of Middle East and Africa
- SECTION 15 - COMPANY SHARE ANALYSIS
- 15.1 Global Implantable Insulin Pumps Market, Company Share Analysis
- 15.2 North America Implantable Insulin Pumps Market, Company Share Analysis
- 15.3 Europe Implantable Insulin Pumps Market, Company Share Analysis
- 15.4 Asia-Pacific Implantable Insulin Pumps Market, Company Share Analysis
- SECTION 16 - COMPANY PROFILES
- 16.1 Medtronic plc
- 16.1.1 Company Snapshot
- 16.1.2 Financial Overview
- 16.1.3 Product Portfolio
- 16.1.4 Recent Developments
- 16.2 F. Hoffmann-La Roche AG
- 16.2.1 Company Snapshot
- 16.2.2 Financial Overview
- 16.2.3 Product Portfolio
- 16.2.4 Recent Developments
- 16.3 SOOIL Developments Co. Ltd.
- 16.3.1 Company Snapshot
- 16.3.2 Financial Overview
- 16.3.3 Product Portfolio
- 16.3.4 Recent Developments
- 16.4 Diamesco Co., Ltd.
- 16.4.1 Company Snapshot
- 16.4.2 Financial Overview
- 16.4.3 Product Portfolio
- 16.4.4 Recent Developments
- 16.5 Apex Medical Devices
- 16.5.1 Company Snapshot
- 16.5.2 Financial Overview
- 16.5.3 Product Portfolio
- 16.5.4 Recent Developments
- 16.6 Tandem Diabetes Care
- 16.6.1 Company Snapshot
- 16.6.2 Financial Overview
- 16.6.3 Product Portfolio
- 16.6.4 Recent Developments
- 16.7 Johnson and Johnson Services Inc.
- 16.7.1 Company Snapshot
- 16.7.2 Financial Overview
- 16.7.3 Product Portfolio
- 16.7.4 Recent Developments
- 16.8 Insulet Corporation
- 16.8.1 Company Snapshot
- 16.8.2 Financial Overview
- 16.8.3 Product Portfolio
- 16.8.4 Recent Developments
- 16.9 Aetna Inc.
- 16.9.1 Company Snapshot
- 16.9.2 Financial Overview
- 16.9.3 Product Portfolio
- 16.9.4 Recent Developments
- 16.10 Diabeloop SACA
- 16.10.1 Company Snapshot
- 16.10.2 Financial Overview
- 16.10.3 Product Portfolio
- 16.10.4 Recent Developments
- SECTION 17 - RELATED REPORTS
- SECTION 18 - DISCLAIMER
RESEARCH METHODOLOGY
The research methodology employed in Uniprism Market Research involves four basic steps namely research and data collection, data pre-processing, modeling and forecasting, quality assurance and output.
RESEARCH AND DATA COLLECTION
A tripod model research technique is followed for research and data collection in which various approaches such as primary research, secondary research, and product mapping are considered.
Primary research basically involves the process of conducting personalized interviews with market related professionals of major market players, investors, distributors, vendors and many more.
The secondary research include data published by government, annual reports, press releases, investor presentations of companies, white papers, certified publications, annual manufacturing limit of the respective industries related to the market, production consumption analysis of certain products respective to the market and many more.
Below mention are few of the sources which we have considered while estimating the market size:
For instance,
- Research articles published on Technium
- Science and MDPI
- Research publications by government approved associations and societies
Product mapping means the process of mapping the list of products that a key player contributes to the market as well as estimating the revenue of those products in order to define the Global Company share analysis of the respective Global Company in global, regional, and country level markets.
DATA PRE-PROCESSING
The term "data pre-processing" refers to the collection of procedures and methods used to clean, modify, and make ready for analysis the raw data gathered during research and data collection. The completion of this phase is necessary to guarantee that the data are reliable, consistent, and appropriate for statistical analysis and other data-driven tasks. The data pre-processing ensures that the information gathered from research and data collection is comparable and expressed in standard units, by the integration of missing data pointers and algorithmic approaches.
MODELING AND FORECASTING
The process of developing mathematical, statistical, or computational representations of real-world occurrences or relationships is known as modelling. These models are intended to replicate and explain market interactions, interdependence, and dynamics. These models are used by Uniprism Market Research to acquire a better knowledge of numerous market characteristics such as customer preferences, pricing elasticity, competition dynamics, and more. Depending on the individual study aims, many types of models are utilized, such as regression models, econometric models, decision tree models, and machine learning models.
Forecasting is the process of predicting future market conditions, trends, and occurrences using past data and models. Forecasting is used by Uniprism Market Research to estimate future sales, demand for products or services, market growth, and other important performance metrics. Forecasting accurately can assist organizations in making educated decisions about resource allocation, pricing, inventory management, and marketing tactics.
We create standardized bottom-up or top-down models that scale by leveraging data science and machine learning technology. All our market models consider the unique market characteristics of each country. Forecasting is based on major market indicators and a combination of traditional methodologies, such as exponential smoothing, time series analysis, regression analysis, and more modern techniques such as machine learning algorithms are all forecasting methodologies. The method chosen is determined on the nature of the data and the specific forecasting aims.
QUALITY ASSURANCE AND OUTPUT
Quality assurance and output involves the process of validation, adjustments, further publications of key market indicators. Extensive plausibility and consistency tests are performed on derived time series to ensure the high degree of quality of our market analysis. This quality assurance procedure also includes rigorous inspection, validation, and editing by an experienced management team to assure the dependability of the published data.